- Loading stock data...
Marvel Biotechnology Inc. is at the forefront of modern pharmaceutical re-purposing technology.
Lead by the dynamic team of Rod Matheson and Mark Williams PhD MBA, Marvel is committed to providing maximum value to it’s shareholders while keeping a laser sharp focus on leading the way to new discoveries in science.
With over 15 years of experience in drug and medical device development Mark joins the Marvel team with an incredible list of accolades.
Author of more than 12 patents, Mark brings his vast expertise in taking companies from discovery to Phase II trials including manufacturing and toxicology.
He is the Co-founder of three companies held privately (sold), as well as on NASDAQ and CSE markets.
The Marvel Model was built on a proven system designed to maximize capital in order to achieve the greatest results.